Hepatitis C Therapy – Related Haematological Side Effects are Associated with Treatment Outcome / Hematološka Neželjena Dejstva Terapije Hepatitisa C Su Povezana Sa Ishodom Lecenja

Publicado en línea: 14 abr 2016

Páginas: 9 - 14

Recibido: 21 abr 2015

Aceptado: 06 jul 2015

DOI: https://doi.org/10.1515/sjecr-2015-0036

Palabras clave

chronic hepatitis C, pegylated interferon alpha 2a, ribavirin, anaemia, thrombocytopenia, leucopoenia, neutropenia

© 2016

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.